A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Standard

A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea : A Systematic Review Sponsored by the World Workshop on Oral Medicine VI. / Wolff, Andy; Joshi, Revan Kumar; Ekström, Jörgen; Aframian, Doron; Pedersen, Anne Marie Lynge; Proctor, Gordon; Narayana, Nagamani; Villa, Alessandro; Sia, Ying Wai; Aliko, Ardita; McGowan, Richard; Kerr, Alexander Ross; Jensen, Siri Beier ; Vissink, Arjan; Dawes, Colin.

I: Drugs in R&D, Bind 17, Nr. 1, 2017, s. 1-28.

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Harvard

Wolff, A, Joshi, RK, Ekström, J, Aframian, D, Pedersen, AML, Proctor, G, Narayana, N, Villa, A, Sia, YW, Aliko, A, McGowan, R, Kerr, AR, Jensen, SB, Vissink, A & Dawes, C 2017, 'A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI', Drugs in R&D, bind 17, nr. 1, s. 1-28. https://doi.org/10.1007/s40268-016-0153-9

APA

Wolff, A., Joshi, R. K., Ekström, J., Aframian, D., Pedersen, A. M. L., Proctor, G., ... Dawes, C. (2017). A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI. Drugs in R&D, 17(1), 1-28. https://doi.org/10.1007/s40268-016-0153-9

Vancouver

Wolff A, Joshi RK, Ekström J, Aframian D, Pedersen AML, Proctor G o.a. A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI. Drugs in R&D. 2017;17(1):1-28. https://doi.org/10.1007/s40268-016-0153-9

Author

Wolff, Andy ; Joshi, Revan Kumar ; Ekström, Jörgen ; Aframian, Doron ; Pedersen, Anne Marie Lynge ; Proctor, Gordon ; Narayana, Nagamani ; Villa, Alessandro ; Sia, Ying Wai ; Aliko, Ardita ; McGowan, Richard ; Kerr, Alexander Ross ; Jensen, Siri Beier ; Vissink, Arjan ; Dawes, Colin. / A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea : A Systematic Review Sponsored by the World Workshop on Oral Medicine VI. I: Drugs in R&D. 2017 ; Bind 17, Nr. 1. s. 1-28.

Bibtex

@article{9bec02a2344b49938653b0f7fbc967f5,
title = "A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI",
abstract = "BACKGROUND: Medication-induced salivary gland dysfunction (MISGD), xerostomia (sensation of oral dryness), and subjective sialorrhea cause significant morbidity and impair quality of life. However, no evidence-based lists of the medications that cause these disorders exist.OBJECTIVE: Our objective was to compile a list of medications affecting salivary gland function and inducing xerostomia or subjective sialorrhea.DATA SOURCES: Electronic databases were searched for relevant articles published until June 2013. Of 3867 screened records, 269 had an acceptable degree of relevance, quality of methodology, and strength of evidence. We found 56 chemical substances with a higher level of evidence and 50 with a moderate level of evidence of causing the above-mentioned disorders. At the first level of the Anatomical Therapeutic Chemical (ATC) classification system, 9 of 14 anatomical groups were represented, mainly the alimentary, cardiovascular, genitourinary, nervous, and respiratory systems. Management strategies include substitution or discontinuation of medications whenever possible, oral or systemic therapy with sialogogues, administration of saliva substitutes, and use of electro-stimulating devices.LIMITATIONS: While xerostomia was a commonly reported outcome, objectively measured salivary flow rate was rarely reported. Moreover, xerostomia was mostly assessed as an adverse effect rather than the primary outcome of medication use. This study may not include some medications that could cause xerostomia when administered in conjunction with others or for which xerostomia as an adverse reaction has not been reported in the literature or was not detected in our search.CONCLUSIONS: We compiled a comprehensive list of medications with documented effects on salivary gland function or symptoms that may assist practitioners in assessing patients who complain of dry mouth while taking medications. The list may also prove useful in helping practitioners anticipate adverse effects and consider alternative medications.",
author = "Andy Wolff and Joshi, {Revan Kumar} and J{\"o}rgen Ekstr{\"o}m and Doron Aframian and Pedersen, {Anne Marie Lynge} and Gordon Proctor and Nagamani Narayana and Alessandro Villa and Sia, {Ying Wai} and Ardita Aliko and Richard McGowan and Kerr, {Alexander Ross} and Jensen, {Siri Beier} and Arjan Vissink and Colin Dawes",
year = "2017",
doi = "10.1007/s40268-016-0153-9",
language = "English",
volume = "17",
pages = "1--28",
journal = "Drugs in R&D",
issn = "1174-5886",
publisher = "Adis International Ltd",
number = "1",

}

RIS

TY - JOUR

T1 - A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea

T2 - A Systematic Review Sponsored by the World Workshop on Oral Medicine VI

AU - Wolff, Andy

AU - Joshi, Revan Kumar

AU - Ekström, Jörgen

AU - Aframian, Doron

AU - Pedersen, Anne Marie Lynge

AU - Proctor, Gordon

AU - Narayana, Nagamani

AU - Villa, Alessandro

AU - Sia, Ying Wai

AU - Aliko, Ardita

AU - McGowan, Richard

AU - Kerr, Alexander Ross

AU - Jensen, Siri Beier

AU - Vissink, Arjan

AU - Dawes, Colin

PY - 2017

Y1 - 2017

N2 - BACKGROUND: Medication-induced salivary gland dysfunction (MISGD), xerostomia (sensation of oral dryness), and subjective sialorrhea cause significant morbidity and impair quality of life. However, no evidence-based lists of the medications that cause these disorders exist.OBJECTIVE: Our objective was to compile a list of medications affecting salivary gland function and inducing xerostomia or subjective sialorrhea.DATA SOURCES: Electronic databases were searched for relevant articles published until June 2013. Of 3867 screened records, 269 had an acceptable degree of relevance, quality of methodology, and strength of evidence. We found 56 chemical substances with a higher level of evidence and 50 with a moderate level of evidence of causing the above-mentioned disorders. At the first level of the Anatomical Therapeutic Chemical (ATC) classification system, 9 of 14 anatomical groups were represented, mainly the alimentary, cardiovascular, genitourinary, nervous, and respiratory systems. Management strategies include substitution or discontinuation of medications whenever possible, oral or systemic therapy with sialogogues, administration of saliva substitutes, and use of electro-stimulating devices.LIMITATIONS: While xerostomia was a commonly reported outcome, objectively measured salivary flow rate was rarely reported. Moreover, xerostomia was mostly assessed as an adverse effect rather than the primary outcome of medication use. This study may not include some medications that could cause xerostomia when administered in conjunction with others or for which xerostomia as an adverse reaction has not been reported in the literature or was not detected in our search.CONCLUSIONS: We compiled a comprehensive list of medications with documented effects on salivary gland function or symptoms that may assist practitioners in assessing patients who complain of dry mouth while taking medications. The list may also prove useful in helping practitioners anticipate adverse effects and consider alternative medications.

AB - BACKGROUND: Medication-induced salivary gland dysfunction (MISGD), xerostomia (sensation of oral dryness), and subjective sialorrhea cause significant morbidity and impair quality of life. However, no evidence-based lists of the medications that cause these disorders exist.OBJECTIVE: Our objective was to compile a list of medications affecting salivary gland function and inducing xerostomia or subjective sialorrhea.DATA SOURCES: Electronic databases were searched for relevant articles published until June 2013. Of 3867 screened records, 269 had an acceptable degree of relevance, quality of methodology, and strength of evidence. We found 56 chemical substances with a higher level of evidence and 50 with a moderate level of evidence of causing the above-mentioned disorders. At the first level of the Anatomical Therapeutic Chemical (ATC) classification system, 9 of 14 anatomical groups were represented, mainly the alimentary, cardiovascular, genitourinary, nervous, and respiratory systems. Management strategies include substitution or discontinuation of medications whenever possible, oral or systemic therapy with sialogogues, administration of saliva substitutes, and use of electro-stimulating devices.LIMITATIONS: While xerostomia was a commonly reported outcome, objectively measured salivary flow rate was rarely reported. Moreover, xerostomia was mostly assessed as an adverse effect rather than the primary outcome of medication use. This study may not include some medications that could cause xerostomia when administered in conjunction with others or for which xerostomia as an adverse reaction has not been reported in the literature or was not detected in our search.CONCLUSIONS: We compiled a comprehensive list of medications with documented effects on salivary gland function or symptoms that may assist practitioners in assessing patients who complain of dry mouth while taking medications. The list may also prove useful in helping practitioners anticipate adverse effects and consider alternative medications.

U2 - 10.1007/s40268-016-0153-9

DO - 10.1007/s40268-016-0153-9

M3 - Review

C2 - 27853957

VL - 17

SP - 1

EP - 28

JO - Drugs in R&D

JF - Drugs in R&D

SN - 1174-5886

IS - 1

ER -

ID: 169135578